Basit öğe kaydını göster

dc.contributor.authorVezir, Emine
dc.contributor.authorCivelek, Ersoy
dc.contributor.authorDibek Mısırlıoğlu, Emine
dc.contributor.authorToyran, Müge
dc.contributor.authorÇapanoğlu, Murat
dc.contributor.authorKarakuş, Esra
dc.contributor.authorKahraman, Tamer
dc.contributor.authorÖzgüner, Meltem
dc.contributor.authorDemirel, Fatma
dc.contributor.authorGürsel, İhsan
dc.contributor.authorKocabaş, Can Naci
dc.date.accessioned2021-03-30T06:54:58Z
dc.date.available2021-03-30T06:54:58Z
dc.date.issued2021en_US
dc.identifier.citationVezir E, Civelek E, Dibek Misirlioglu E, Toyran M, Capanoglu M, Karakus E, Kahraman T, Ozguner M, Demirel F, Gursel I, Kocabas C, N: Effects of Obesity on Airway and Systemic Inflammation in Asthmatic Children. Int Arch Allergy Immunol 2021. doi: 10.1159/000513809en_US
dc.identifier.urihttps://doi.org/10.1159/000513809
dc.identifier.urihttps://hdl.handle.net/20.500.12809/9108
dc.description.abstractBackground: Obese asthma is a complex syndrome with certain phenotypes that differ in children and adults. There is no clear evidence regarding the presence of additive or synergistic pathological interaction between obesity and asthma in children. Objectives: Our aim was to demonstrate the interaction of obesity and asthma in children in terms of airway and systemic inflammation by a controlled observational study. Methods: Four groups were formed: asthma obese (AO), asthma nonobese (ANO), non-AO (NAO), nonasthma nonobese (NANO). Spirometry test, fractional exhaled nitric oxide (FeNO) test, skin prick test, serum inflammatory biomarkers (C-reactive protein, C3, C4, adiponectin, leptin, resistin, periostin, YKL-40, Type 1, and Type 2 cytokines) were conducted and evaluated in all participants. Sputum inflammatory cells (sputum eosinophils and neutrophils) were evaluated in patients who could produce induced sputum and obesity-asthma interactions were determined. Results: A total of 153 participants aged 6-18 years were included in the study, including the AO group (n = 46), the ANO group (n = 45), the NAO group (n = 30), and the NANO group (n = 32). IL-4 (p < 0.001), IL-5 (p < 0.001), IL-13 (p < 0.001), resistin (p < 0.001), and YKL-40 (p < 0.001) levels were higher in patients with asthma independent of obesity. The lowest adiponectin level was found in the AO group and obesity-asthma interaction was detected (p < 0.001). Sputum eosinophilia (p < 0.01), sputum neutrophilia (p < 0.01), and FeNO levels (p = 0.07) were higher in asthmatic patients independent of obesity. In the group with paucigranulocytic inflammation, resistin and YKL-40 levels were significantly lower than in the group without paucigranulocytic inflammation (p < 0.01). Conclusion: No interaction was found between obesity and asthma in terms of airway inflammation. Interaction between obesity and asthma was shown in terms of adiponectin level and resistin/adiponectin and leptin/adiponectin ratios. It was found that serum YKL-40 and resistin levels could be associated with airway inflammation.en_US
dc.item-language.isoengen_US
dc.publisherKargeren_US
dc.relation.isversionof10.1159/000513809en_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdiponectinen_US
dc.subjectAirway inflammationen_US
dc.subjectAsthmaen_US
dc.subjectChildhooden_US
dc.subjectObesityen_US
dc.subjectSystemic inflammationen_US
dc.titleEffects of Obesity on Airway and Systemic Inflammation in Asthmatic Childrenen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.authorID0000-0001-8859-7187en_US
dc.contributor.institutionauthorKocabaş, Can Naci
dc.identifier.volume1en_US
dc.identifier.issue11en_US
dc.relation.journalInternational Archives of Allergy and Immunologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster